Published 1 month ago

Distribution Destinations for Potentially Hazardous Benikoji Not Fully Known; Ingredient Sold by Japan’s Kobayashi Pharmaceutical

Summary by Ground News

Kobayashi Pharmaceutical Co. produced 18.5 tons of benikoji in 2023. The company used 2.4 tons of it to make its own supplement products. It sold the other 16.1 tons to 52 business partners. Some of that amount contains an unknown substance that is highly likely to cause kidney problems.

0 Articles

All

Left

Center

Right

読売新聞オンライン

Distribution Destinations for Potentially Hazardous Benikoji Not Fully Known; Ingredient Sold by Japan’s Kobayashi Pharmaceutical

The distribution destinations for a significant amount of Kobayashi Pharmaceutical Co.’s benikoji red rice mold, some of which contains an unknown substance with possible health risks, have yet to be fully identified.

1 month ago·Japan

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.